结肠酸介导的菌体耐药性增强了高风险的全球克隆大肠杆菌ST41010的毒性
Jieying Tu1, Jun Yang2, Kewei Song1
1State Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Zoonosis of Ministry of Agricultural and Rural Affairs, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
PLoS pathogens
|December 22, 2025
概括
一种针对多药耐药性大肠杆菌ST410的新菌体疗法面临着快速的耐药性. 突变者过度产生胆汁酸,增强毒性和逃避菌体,但四菌体尾酒证明有效.
科学领域:
- 微生物学和病毒学
- 细菌治疗疗法是一种细菌治疗.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 耐多药性大肠杆菌 (Escherichia coli ST410) 是一个重大的临床挑战.
- 菌体治疗为抗生素提供了替代品,但面临着耐药性问题.
研究的目的:
- 为了研究对针对大肠杆菌ST410.4的菌体的抗性机制.
- 探索菌体耐药性,毒性和囊生产之间的联系.
- 开发一种有效的菌体战略来对抗ST410感染.
主要方法:
- 对大肠杆菌 (E. coli) ST410.10的性细菌菌体的分离和表征.
- 在体外和体内实验,以评估菌体耐药性和细菌毒性.
- 转录和遗传分析以确定耐药性途径.
- 开发和测试一个多相尾酒.
主要成果:
- 在大肠杆菌ST410中通过受体突变和酸过度生产,出现了快速的菌体耐药性.
- 结肠酸的过度生产赋予了广泛的菌体耐药性,通过逃避巨细胞灭菌,增强了毒性,并加速了小鼠的死亡率.
- 该Rcs途径与胆氨酸过度生产有关.
- 一种四相尾酒在感染模型中显示出强大的治疗效果.
结论:
- 大肠杆菌ST410中的菌体耐药性可以通过囊介导的免疫逃避与增加的毒性相结合.
- 酸在这种双重表型中起着至关重要的作用,影响了菌体治疗的疗效.
- 一个多相尾酒策略对于克服耐药性和确保成功的菌体治疗至关重要.
相关概念视频
Lysogenic Cycle of Bacteriophages
67.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.2K
Stringent Response in E. coli
257
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
257
Viral Replication: Lytic Cycle
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.1K
Antibiotic Selection
59.3K
Overview
59.3K
Development of Antibiotic Resistance
1.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
Viral Replication: Lysogenic Cycle
1.2K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.2K


